Clinical feasibility of ASL-MRI to assess perfusional delay in cerebrovascular disease

Clinical feasibility of ASL-MRI to assess perfusional delay in cerebrovascular disease - ASL-MRI in cerebrovascular disease

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000028771

Enrollment

550

Registered

2017-08-23

Start date

2011-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cerebrovascular disease (moyamoya disease, atherosclerotic cerebrovascular disease, stroke, arteriovenous malformation etc.)

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. All patients with cerebrovascular disease evaluated with ASL-MRI (retrospective group: 2011/4/1-2017/9/30. Any age, any tyepe of cerebrovascular disease) 2. All patients with cerebrovascular disease evaluated with ASl-MRI (prospective group: 2017/9/30-2020/6/30. Any age, any tyepe of cerebrovascular disease) 3. Normal subjects (>=20 year-old, no upper limit)

Exclusion criteria

Exclusion criteria: *denial from the patient *neurological disease other than cerebrovascular disease (brain tumor, epilepsy, etc) *unable to perform MRI

Design outcomes

Primary

Measure	Time frame
1. correlation with other modalities (PET, SPECT, DSC) 2. difference among disease (moyamoya disease and atherosclerotic cerebrovascular disease etc.) and normal subjects 3. chronological change including postoperative change 4. difference among age 5. correlation between arterial transit time calculated from ASL-MRI using 5 postlabeling delays and ASL ratio in normal subjects	—

Countries

Japan

Contacts

Public ContactShoko Hara

Tokyo Medical and Dental University Neurosurgery

shara.nsrg@tmd.ac.jp0358035266

Outcome results